Reducing Anti-Kickback Risks Associated With Medical Products

On October 3, Washington, D.C. health care and life sciences partner John Bentivoglio participated in a webinar focusing on anti-kickback statute (AKS) enforcement proceedings against medical products companies. Topics included recent trends in AKS enforcement, safe harbors and compliance with AKS requirements, including government expectations and requirements, investigative best practices, self-disclosure and privilege issues.